280 related articles for article (PubMed ID: 27585700)
1. Correlation of Tumor Immunohistochemistry with Dynamic Contrast-Enhanced and DSC-MRI Parameters in Patients with Gliomas.
Nguyen TB; Cron GO; Bezzina K; Perdrizet K; Torres CH; Chakraborty S; Woulfe J; Jansen GH; Thornhill RE; Zanette B; Cameron IG
AJNR Am J Neuroradiol; 2016 Dec; 37(12):2217-2223. PubMed ID: 27585700
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the Diagnostic Accuracy of DSC- and Dynamic Contrast-Enhanced MRI in the Preoperative Grading of Astrocytomas.
Nguyen TB; Cron GO; Perdrizet K; Bezzina K; Torres CH; Chakraborty S; Woulfe J; Jansen GH; Sinclair J; Thornhill RE; Foottit C; Zanette B; Cameron IG
AJNR Am J Neuroradiol; 2015 Nov; 36(11):2017-22. PubMed ID: 26228886
[TBL] [Abstract][Full Text] [Related]
3. Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis.
Santarosa C; Castellano A; Conte GM; Cadioli M; Iadanza A; Terreni MR; Franzin A; Bello L; Caulo M; Falini A; Anzalone N
Eur J Radiol; 2016 Jun; 85(6):1147-56. PubMed ID: 27161065
[TBL] [Abstract][Full Text] [Related]
4. Comparing perfusion metrics obtained from a single compartment versus pharmacokinetic modeling methods using dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade.
Law M; Young R; Babb J; Rad M; Sasaki T; Zagzag D; Johnson G
AJNR Am J Neuroradiol; 2006 Oct; 27(9):1975-82. PubMed ID: 17032878
[TBL] [Abstract][Full Text] [Related]
5. Pixel-by-Pixel Comparison of Volume Transfer Constant and Estimates of Cerebral Blood Volume from Dynamic Contrast-Enhanced and Dynamic Susceptibility Contrast-Enhanced MR Imaging in High-Grade Gliomas.
Alcaide-Leon P; Pareto D; Martinez-Saez E; Auger C; Bharatha A; Rovira A
AJNR Am J Neuroradiol; 2015 May; 36(5):871-6. PubMed ID: 25634715
[TBL] [Abstract][Full Text] [Related]
6. Prospective comparative diagnostic accuracy evaluation of dynamic contrast-enhanced (DCE) vs. dynamic susceptibility contrast (DSC) MR perfusion in differentiating tumor recurrence from radiation necrosis in treated high-grade gliomas.
Zakhari N; Taccone MS; Torres CH; Chakraborty S; Sinclair J; Woulfe J; Jansen GH; Cron GO; Thornhill RE; McInnes MDF; Nguyen TB
J Magn Reson Imaging; 2019 Aug; 50(2):573-582. PubMed ID: 30614146
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic accuracy of dynamic contrast-enhanced MR imaging using a phase-derived vascular input function in the preoperative grading of gliomas.
Nguyen TB; Cron GO; Mercier JF; Foottit C; Torres CH; Chakraborty S; Woulfe J; Jansen GH; Caudrelier JM; Sinclair J; Hogan MJ; Thornhill RE; Cameron IG
AJNR Am J Neuroradiol; 2012 Sep; 33(8):1539-45. PubMed ID: 22442046
[TBL] [Abstract][Full Text] [Related]
8. Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade.
Law M; Yang S; Babb JS; Knopp EA; Golfinos JG; Zagzag D; Johnson G
AJNR Am J Neuroradiol; 2004 May; 25(5):746-55. PubMed ID: 15140713
[TBL] [Abstract][Full Text] [Related]
9. Brain Gliomas: Multicenter Standardized Assessment of Dynamic Contrast-enhanced and Dynamic Susceptibility Contrast MR Images.
Anzalone N; Castellano A; Cadioli M; Conte GM; Cuccarini V; Bizzi A; Grimaldi M; Costa A; Grillea G; Vitali P; Aquino D; Terreni MR; Torri V; Erickson BJ; Caulo M
Radiology; 2018 Jun; 287(3):933-943. PubMed ID: 29361245
[TBL] [Abstract][Full Text] [Related]
10. The assessment of immature microvascular density in brain gliomas with dynamic contrast-enhanced magnetic resonance imaging.
Jia ZZ; Gu HM; Zhou XJ; Shi JL; Li MD; Zhou GF; Wu XH
Eur J Radiol; 2015 Sep; 84(9):1805-9. PubMed ID: 26066470
[TBL] [Abstract][Full Text] [Related]
11. Quantitative Assessment of Tumor Cell Proliferation in Brain Gliomas with Dynamic Contrast-Enhanced MRI.
Jiang JS; Hua Y; Zhou XJ; Shen DD; Shi JL; Ge M; Geng QN; Jia ZZ
Acad Radiol; 2019 Sep; 26(9):1215-1221. PubMed ID: 30416002
[TBL] [Abstract][Full Text] [Related]
12. Histogram analysis of T2*-based pharmacokinetic imaging in cerebral glioma grading.
Liu HS; Chiang SW; Chung HW; Tsai PH; Hsu FT; Cho NY; Wang CY; Chou MC; Chen CY
Comput Methods Programs Biomed; 2018 Mar; 155():19-27. PubMed ID: 29512499
[TBL] [Abstract][Full Text] [Related]
13. Textural features of dynamic contrast-enhanced MRI derived model-free and model-based parameter maps in glioma grading.
Xie T; Chen X; Fang J; Kang H; Xue W; Tong H; Cao P; Wang S; Yang Y; Zhang W
J Magn Reson Imaging; 2018 Apr; 47(4):1099-1111. PubMed ID: 28845594
[TBL] [Abstract][Full Text] [Related]
14. Dynamic susceptibility contrast and dynamic contrast-enhanced MRI characteristics to distinguish microcystic meningiomas from traditional Grade I meningiomas and high-grade gliomas.
Hussain NS; Moisi MD; Keogh B; McCullough BJ; Rostad S; Newell D; Gwinn R; Foltz G; Mayberg M; Aguedan B; Good V; Fouke SJ
J Neurosurg; 2017 Apr; 126(4):1220-1226. PubMed ID: 27285539
[TBL] [Abstract][Full Text] [Related]
15. Do cerebral blood volume and contrast transfer coefficient predict prognosis in human glioma?
Mills SJ; Patankar TA; Haroon HA; Balériaux D; Swindell R; Jackson A
AJNR Am J Neuroradiol; 2006 Apr; 27(4):853-8. PubMed ID: 16611778
[TBL] [Abstract][Full Text] [Related]
16. Comparison between intensity normalization techniques for dynamic susceptibility contrast (DSC)-MRI estimates of cerebral blood volume (CBV) in human gliomas.
Ellingson BM; Zaw T; Cloughesy TF; Naeini KM; Lalezari S; Mong S; Lai A; Nghiemphu PL; Pope WB
J Magn Reson Imaging; 2012 Jun; 35(6):1472-7. PubMed ID: 22281731
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic Accuracy of Arterial Spin-Labeling, Dynamic Contrast-Enhanced, and DSC Perfusion Imaging in the Diagnosis of Recurrent High-Grade Gliomas: A Prospective Study.
Nguyen TB; Zakhari N; Velasco Sandoval S; Guarnizo-Capera A; Alexios Gulak M; Woulfe J; Jansen G; Thornhill R; Majtenyi N; Cron GO
AJNR Am J Neuroradiol; 2023 Feb; 44(2):134-142. PubMed ID: 36702501
[TBL] [Abstract][Full Text] [Related]
18. Reproducibility of dynamic contrast-enhanced MRI and dynamic susceptibility contrast MRI in the study of brain gliomas: a comparison of data obtained using different commercial software.
Conte GM; Castellano A; Altabella L; Iadanza A; Cadioli M; Falini A; Anzalone N
Radiol Med; 2017 Apr; 122(4):294-302. PubMed ID: 28070841
[TBL] [Abstract][Full Text] [Related]
19. Apparent diffusion coefficient and cerebral blood volume in brain gliomas: relation to tumor cell density and tumor microvessel density based on stereotactic biopsies.
Sadeghi N; D'Haene N; Decaestecker C; Levivier M; Metens T; Maris C; Wikler D; Baleriaux D; Salmon I; Goldman S
AJNR Am J Neuroradiol; 2008 Mar; 29(3):476-82. PubMed ID: 18079184
[TBL] [Abstract][Full Text] [Related]
20. Impact of Software Modeling on the Accuracy of Perfusion MRI in Glioma.
Hu LS; Kelm Z; Korfiatis P; Dueck AC; Elrod C; Ellingson BM; Kaufmann TJ; Eschbacher JM; Karis JP; Smith K; Nakaji P; Brinkman D; Pafundi D; Baxter LC; Erickson BJ
AJNR Am J Neuroradiol; 2015 Dec; 36(12):2242-9. PubMed ID: 26359151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
